S22-104 Synthetic Transcription Elongation Factors to Target Mutations in Cancer Genomes Researchers at Stanford have developed synthetic transcription elongation factors (Syn-TEFs) to treat proliferative diseases, including repeat expansion mutations in cancer. Graham Erwin Michael Snyder